A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease

2008743 citationsJournal Article

Authors

Good health and well-being

Published in: Gastroenterology

Volume 135, Issue 4, pp. 1130-1141

Field-Weighted Citation Impact: 28.78